PubMed ID:
9233703
Public Release Type:
Journal
Publication Year: 1997
Affiliation: Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA.
DOI:
https://doi.org/10.1097/00007890-199707150-00013
Authors:
Badley AD,
DeBernardi M,
Keating MR,
Marshall WF,
Patel R,
Paya CV,
Porayko MK,
Seaberg EC,
Steers JL,
Walker RC,
Wiesner RH,
Wilhelm MP,
Zetterman R
Studies:
Liver Transplantation Database
The optimal prophylactic regimen to prevent cytomegalovirus (CMV) infection and disease in orthotopic liver-transplant patients remains to be established. We tested whether a combination of intravenous ganciclovir (GCV) followed by high dosages of oral acyclovir (ACV) for 4 months provided a higher degree of protection from CMV than oral ACV alone.